Eagle Genomics is making much use of open data on behalf of its customers to help them identify competitive advantage from their own data.
December 2017, Cambridge, UK
Eagle Genomics is pleased to announce the appointment of Nicola Blackwood to its Advisory Board. Nicola brings a wealth of experience from a parliamentary career which included positions as Chair of the Science &..
Selecting valuable patient cohorts for cancer biomarker discovery
Providing a scientist with prioritised datasets based on their scientific relevance to the research that the scientist wants to carry forward, allows for improved data selection,..
Join a panel of experts, including Alexandre Passioukov, VP Translational Medicine at Pierre Fabre, Xose Fernandez, Chief Data Officer at Institut Curie and Abel Ureta-Vidal, CEO at Eagle Genomics, as they discuss their first-hand experience of..
Content is something we're never short of. In a digital world, information is never more than a click of a button away through search, social media, bloggers, apps... and constantly accessible through various devices.
Over the last 3 years, Eagle has been involved in a EU funded project, sysVASC, a bench to bedside program with a systems biology approach to identify new targets of disease progression in cardio-vascular disease. This disease killed an estimated
The Royal Society of Medicine’s Medical Innovations Summit, held on the 16th September 2017, brought together international innovators and speakers, from the medical and healthcare sector, to share their knowledge and expertise.
2-3 November 2017, Paradise Point Resort & Spa, San Diego, USA
Eagle Genomics will be exhibiting at the 5th Microbiome R&D and Business Collaboration Forum - Booth #1 in San Diego from 2-3 November 2017.
We'll be exhibiting at this year's BioData World Congress, as well as sponsoring the Pre-Conference Workshop on the 1st November.